DEVELOPMENT OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS DURING THERAPY OF PSEUDOMONAS AERUGINOSA INFECTIONS
- 1 June 1982
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 319 (8287) , 1466
- https://doi.org/10.1016/s0140-6736(82)92473-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Susceptibility patterns of bacteria following therapy with piperacillinJournal of Antimicrobial Chemotherapy, 1982
- Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1981
- Ceftazidime: in-vitro antibacterial activity and susceptibility to -lactamases compared with that of cefotaxime, moxalactam and other -lactam antibioticsJournal of Antimicrobial Chemotherapy, 1981
- Selection of variants of pseudomonas aeruginosa resistant to beta-lactam antibioticsInfection, 1980
- In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamasesAntimicrobial Agents and Chemotherapy, 1980
- Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenesInfection, 1979
- Clinical and Pharmacological Studies of Ticarcillin in Gram-Negative InfectionsAntimicrobial Agents and Chemotherapy, 1976
- SENSITIVITY OF PSEUDOMONAS ÆRUGINOSA TO ANTIBIOTICS: EMERGENCE OF STRAINS HIGHLY RESISTANT TO CARBENICILLINThe Lancet, 1969
- Carbenicillin Resistance in Pseudomonas aeruginosa from Clinical MaterialBMJ, 1969